Video Library

Anxiety and depression are common among cancer patients and survivors. Acceptance and commitment therapy is an effective tool for these problems. This presentation discusses the mental health challenges of transplant and GVHD patients and how this therapy can help them.

Sickle cell disease disproportionately affects African Americans. However, stem cell transplants and gene therapy offer promising treatment options. This presentation describes these treatments, their outcomes, and which treatments are appropriate for which patients.

The number of long-term survivors of hematopoietic cell transplants (bone marrow, stem cell, and cord blood) is dramatically increasing. However, up to two thirds of survivors report at least one chronic health condition as a late effect of treatment. This presentation describes these effects and interventions to treat them.

Autologous stem cell transplants use the patient’s own stem cells to rescue him or her from the effects of high-dose chemotherapy. This type of transplant is most often used to treat patients with multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma. This presentation discusses the transplant process, and common early and late complications.

A pediatric bone marrow transplant can cure a child’s disease, but it can also create a number of physical, emotional and financial issues that need to be addressed, even when the child becomes an adult. This presentation discusses common challenges children face after transplant, and strategies to provide them with a good quality of life long-term.

COVID-19 and its variants present ongoing risks to the general population and added risks for cancer patients, people with weak immune systems, and transplant survivors. This presentation reviews the basics about COVID-19, prevention strategies, recent variants, available therapies, and vaccine responses and provides specific advice for cancer patients and survivors.

Graft-versus-Host Disease (GVHD) is a common condition after a bone marrow or stem cell transplant that uses cells from a donor (an allogeneic transplant). The donor cells are called the “graft” and the patient is called the “host”. When the donor’s immune cells (the graft) are transplanted in the patient’s body (the host) they often unleash an immune system attack against the patient’s organs and tissues which can be mild, moderate or severe.

Caregiving for transplant recipients is a demanding task for which there is little preparation. Caregivers face practical, emotional, and social challenges caring for transplant recipients while also maintaining their own roles. This presentation discusses caregiver challenges and offers some methods for meeting them.

Transplant recipients face several risks to long-term heart health arising from their cancer treatment. This presentation identifies these risks and offers strategies to minimize them and foster healthy, long-term survival.

Key Points: (02:43) Dry eyes from GVHD is more severe than common dry eyes and can lead to corneal abrasions . (03:37) Blood vessels can grow into the cornea, cause

Bone marrow and stem cell transplant recipients have an increased risk of osteoporosis and bone fractures. Life-style changes can improve bone health, but in more serious cases, medications may be required. This presentation reviews risk factors and effective remedies for bone problems in transplant patients.

Secondary cancers sometimes occur after a bone marrow, stem cell transplant or cord blood transplant. Frequent screening can help detect secondary cancers early when treatment is most effective. Lifestyle modifications can also reduce the risk of developing certain cancers after transplant.